-+ 0.00%
-+ 0.00%
-+ 0.00%

Fulcrum Therapeutics Expects Current Cash Runway Be Sufficient To Fund Operating Requirements Into At Least 2027

Benzinga·05/01/2025 11:08:15
Listen to the news

Cash Runway Guidance

Based on its current operating plans, Fulcrum continues to expect that its current cash, cash equivalents, and marketable securities will be sufficient to fund its operating requirements into at least 2027.